fda approves first oral glp-1 obesity drug august 21 2025 The approved a new pill from Eli Lilly on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication Orforglipron, approved as Foundayo on

Green tea A powerful antioxidant and anti-inflammatory agent, green tea calms irritated skin, helps with discoloration, and regulates oil production

Enhanced Recovery Between Workouts IGF-1 LR3 speeds up muscle tissue repair and reduces soreness, making it particularly useful during high-volume training or CrossFit-style programming

Adverse systemic effects only showed up in animal studies at exposures roughly 200x higher than what people get from cosmetics

Private doctor Expect to pay anywhere from $50 to $250 in private clinics

Cannot redeclare control with same name "grid_2_qv_cta_background_color"

doi: 10.1007/s12011-019-01923-z 49 WenXWangLLiFYuX